NCT07330362 The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System.
| NCT ID | NCT07330362 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zhujiang Hospital |
| Condition | Chronic Glomerulonephritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,900 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,900 participants in total. It began in 2024-07-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research project aims to collect images from patients with chronic glomerulonephritis. For each subject, the images obtained from renal biopsy will undergo evaluation by both the diagnostic model and the 'gold standard' diagnosis by pathologists. The researchers will test the subjects using the diagnostic model and compare the results with the known 'gold standard' diagnosis, in order to evaluate the AUC, specificity, and sensitivity of the diagnostic model.
Eligibility Criteria
Inclusion Criteria: 1. Voluntary signing of informed consent form; 2. Patients clinically diagnosed or suspected of having chronic kidney disease according to the 2023 KDIGO Clinical Practice Guideline for the Evaluation and Management of Kidney Disease; 3. Undergoing renal biopsy and pathological specimen preparation. Exclusion Criteria: 1. Biopsy tissue from donor kidney or transplanted kidney; 2. Poor quality of pathological specimen, unable to conduct pathological diagnosis.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07330362 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 79 Years, studying Chronic Glomerulonephritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07330362 currently recruiting?
Yes, NCT07330362 is actively recruiting participants. Contact the research team at 764709402@qq.com for enrollment information.
Where is the NCT07330362 trial being conducted?
This trial is being conducted at Guangzhou, China, Guangzhou, China.
Who is sponsoring the NCT07330362 clinical trial?
NCT07330362 is sponsored by Zhujiang Hospital. The trial plans to enroll 2,900 participants.